Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
SRC Biosciences
AddedFeb 16, 2024
UpdatedJun 18, 2026
SRC Biosciences

SRC Biosciences

SRC Biosciences: A tech firm specializing in the development and maintenance of stereology systems.

HQ
Tampa, FL, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

SRC Biosciences is a technology company focused on developing and maintaining advanced stereology systems. Their core mission is to accelerate scientific discovery through unbiased stereology, offering products such as the Stereologer Systems. They also provide expert stereology analysis and tissue processing services. The company aims to enhance the quality of stereological research through superior engineering and professional support, catering primarily to the scientific and medical research markets.

SRC Biosciences has made significant strides in the field of stereology, contributing to more accurate and efficient research methodologies. They offer monthly webinars to educate and engage with the scientific community, demonstrating their commitment to knowledge sharing and professional development. The company's impact is evident in the improved research outcomes facilitated by their advanced systems and expert services.

SRC Biosciences - Similar Companies

Fluidigm logo

Fluidigm

standardbio.com

Systems Biology Research Group logo

Systems Biology Research Group

Standard BioTools logo

Standard BioTools

standardbio.com

Vitra Bioscience logo

Vitra Bioscience

Boca Biolistics logo

Boca Biolistics

Stereovision Imaging logo

Stereovision Imaging

BioAnalytics logo

BioAnalytics

ClearLight Biotechnologies logo

ClearLight Biotechnologies

Bioinformatics logo

Bioinformatics

bioinfoinc.com

InVivo Biosystems logo

InVivo Biosystems

Stellaromics logo

Stellaromics

stellaromics.com

Scribe Biosciences logo

Scribe Biosciences

Spheringenics logo

Spheringenics

eBioinformatics logo

eBioinformatics

Cell Microsystems logo

Cell Microsystems

SRC Biosciences - Quick Facts

Who are SRC Biosciences' competitors?

Companies similar to SRC Biosciences include Fluidigm, Systems Biology Research Group, Standard BioTools and Vitra Bioscience.

When was SRC Biosciences founded?

SRC Biosciences was founded in 2000.

Where is SRC Biosciences' headquarters located?

SRC Biosciences' headquarters is located in Tampa, FL, US.

When was SRC Biosciences' last funding round?

SRC Biosciences' most recent funding round was for $985.4k (USD) in August 2019.

How much has SRC Biosciences raised to-date?

As of Aug 28, 2019, SRC Biosciences has raised a total of $1.2M (USD).

How many employees does SRC Biosciences have?

SRC Biosciences has 7 employees as of Feb 4, 2024.

SRC Biosciences - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Stereology Systems
Tags
  • Biotech
  • Consulting
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software